Seventh, I agree with you about Missling's appearances in so many investor and scientific conferences; he sounds very confident and credible. One strong sign for me is the "poison pill" proposal to be voted at the upcoming shareholder meeting. The management team and BOD would not be doing that if they did not have the goods to back them up. Imagine what the shareholder meeting would be like if the data to be presented at the end of March is not strong. They know what they have.
While the PPS action is disappointing for now, I believe that patience will reward those who are in it for the long haul. Obviously, this is just an opinion from someone who is heavily vested in Anavex.
Cheers!
News 
Market Data 
Discover 
